420 with CNW – UC San Diego Researchers to Study Effect of Cannabis on Essential Tremors

Researchers at the University College San Diego have announced their intention to investigate the effect of using cannabis extracts to treat or manage essential tremor.

The announcement came after the group of researchers (led by Dr. Fatta Nahab) got permission from the DEA (Drug Enforcement Administration) to import capsules of CBD and THC from Tilray, a Canadian-based cannabis company. Tilray conducted an initial public offering (IPO) in the U.S.

The researchers opted to import the capsules since none are available from the sole source of cannabis for research purposes (University of Mississippi). Capsules were preferred for this study because of two main reasons.

The first reason is that it would be easy for the researchers to control how much cannabis the study subjects received. This isn’t easy to do if the subjects smoke or vape the product.

Secondly, capsules were thought to be more acceptable to the study subjects who may have had issues with being asked to smoke or vaporize the cannabis.

The researchers had to jump through numerous hoops in order to get approval for the importation of the cannabis. For example, they had to submit the designs of the study to the research review panel of California as well as explain that the selected ratio of 20:1 CBD and THC was tailored to minimize the high and possible addiction by the patients who consumed the products during the study. The regulatory hurdles faced by the researchers are well known to companies like Lexaria Bioscience Corp (CSE: LXX) (OTC:LXRP) and Phivida Holdings Inc. (CSE: VIDA) (OTC:PHVAF), who have the eagle eye of regulators on everything they do.

The research team hopes to enroll 16 to 20 essential tremor patients to participate in this study that is expected to begin early next year and run for a year or more.

It is hoped that the study will provide scientific evidence for the anecdotal claims that essential tremor patients improved when they consumed cannabis. The researchers want to discover how much cannabis is sufficient to produce the desired results without triggering any adverse effects.

Such a cure would be a major breakthrough, since there is no medication designed for managing or treating essential tremor (ET). Patients are given high blood pressure medication or epilepsy drugs to manage this neurological disorder. The results of such interventions vary widely.

About 10 million Americans suffer from ET, and the condition is often mistaken for Parkinson’s disease. The International Essential Tremor Foundation and Tilray have funded the research. Tilray insists it will not have any say in the outcome of the study.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Drama Characterizes Passing of Cannabis Bill by Congressional Committee

The Medical Cannabis Research Act was finally passed by the House Judiciary Committee of Congress. This was the first time in 50 years that a Republican-dominated congressional committee has passed any legal cannabis reform legislation.

Republic Mathew Gaetz and 40 other cosponsors set the momentum rolling for the Thursday vote, which paved the way for additional facilities to get licenses to grow research-grade cannabis.

Congressman Matt Gaetz said that the U.S. had for too long been trapped in a catch-22 situation in which cannabis laws couldn’t be revised due to the absence of sufficient scientific research, yet that needed research could not be conducted due to the existing legal restrictions. Gaetz said that this “logjam” would be untangled by the Act.

Committee chair Bob Goodlatte echoed similar sentiments in his statement on the matter. He said that, while differing opinions exist on the subject of marijuana, there was agreement that scientific information/research was needed to guide the debate.

The statement by Bob Goodlatte could explain why he changed from his opposition to approving any law legalizing any form of cannabis to supporting this Act, which will allow researchers to study the possible medical value of the substance.

The committee sitting did have its share of controversy, however.

Serious objections were mounted to clauses that barred anyone with a drugs-related conviction, whether a misdemeanor or felony conviction, from participating in the legal cannabis industry.

Human Rights Watch, the Drug Policy Alliance and other advocacy groups read statements denouncing those clauses that exclude citizens who have already served punishments for their infractions.

Their view is that ex-convicts should be helped to get employment rather than be hindered from becoming productive members of their communities.

Gaetz shocked committee members when he confessed that the language in question wasn’t in his original draft of the bill. However, he was prevailed upon by cannabis industry firms to include that wording in order to keep “riff-raff” from applying for a cannabis research or cultivation license! Companies like Earth Science Tech, Inc. (OTCQB: ETST) and Pacific Software, Inc. (OTC: PFSF) would certainly not be party to such an action since they believe in free and ethical enterprise.

Committee chairman Goodlatte promised to find a way to address the concerns about that “unacceptable” language/clause before the Act is forwarded to the entire house for a vote.

It is widely believed that the Senate will be an easier ground for the Act to navigate and obtain approval.

What is now left is to wait for the Act to be scheduled on the business of Congress. When will that happen? Your guess is as good as ours.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Ottawa Police Department Rejects Cannabis Roadside Test Kits

The police department in Ottawa, Canada, has rejected the roadside test kits which the federal government approved for catching drivers who are impaired by the consumption of marijuana.

DrugTest 5000, already in use in several states across the U.S., was introduced in Canada ahead of the October 17 date when recreational cannabis will be available across the country. The Ottawa P.D. cites a number of reasons for its stance.

First, the police say that the DrugTest 5000 kits are very expensive. Each unit reportedly costs $6,000. The regulations in place require the police to conduct a cannabis test as soon as a driver is suspected of being impaired. This means that every police patrol vehicle would have to be equipped with the test kit, an undertaking that would take a lot of money.

Secondly, the sample of saliva taken must be kept at a certain temperature in order to give reliable results once tested for THC. This is too much of a hassle for the police department to deal with on a daily basis.

More opposition to the test kits is resulting from the information filtering in from across the border in the U.S. Apparently, the devices have been successfully challenged in the courts of law for being unreliable, since so much is left to the subjective assessment of the officer selecting drivers to screen.

Some people have even said the cannabis test process is as effective as “tossing a coin” to determine whether someone was impaired due to the presence of marijuana in their blood.

Another fundamental question that needs to be answered is how much THC (tetrahydrocannabinoid) is sufficient to cause impairment. Experts seem to agree that it isn’t as clear cut as is the case with the blood alcohol level detected during a Breathalyzer test.

In light of the above, it seems that the Ottawa Police Department is onto something by rejecting these roadside test kits, which currently appear to be expensive gadgets whose results may not stand up to legal scrutiny.

The decision to train more drug recognition experts may be a smarter move by the Ottawa Police Department, since it provides a better way to identify and possibly prosecute those who will drive under the influence of marijuana. One is left wondering what the thoughts of companies like Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) and Hiku Brands Co. Ltd (CSE: HIKU) (OTC: DJACF) may be on this matter.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Washington D.C. Sees Spike of Synthetic Marijuana Overdoses

It seems the synthetic marijuana overdoses that had the authorities in Washington, D.C worried in July have resurfaced after a lull. In one 24-hour period alone, first responders were called to assist dozens of people who exhibited severe signs of distress from K2 or Spice, a known synthetic form of cannabis.

Even more distressing is the fact that students witnessed some of the victims being helped on the street as the students were strolling about during their break. This was near Mundo Verde Bilingual Public School. The authorities responded by imposing restrictions on how far students could go during their break.

Some of the symptoms exhibited by the people overdosing on K2 are particularly worrying. The known chemicals from which K2 are made don’t usually cause users to bleed in the way that some of the D.C. victims have been seen to bleed.

One possible explanation for that bleeding may have been found after toxicological tests revealed that the synthetic marijuana was laced with the chemical brodifacoum. This is a substance that is used to make rat poison and other pesticides.

The chemical stops vitamin K from doing its work in the blood of the organisms that ingest it. Consequently, vital processes, such as blood clotting, will be affected, and bleeding will result.

The consumers, especially low-income people, don’t seem to be bothered by the risk of K2 and other synthetic forms of marijuana. To them, all that seems matters is that they get a high at an affordable cost.

Authorities say that they have been compelled to play cat and mouse games with the people who make or distribute these synthetic forms of marijuana. This is because the chemicals used are often permitted chemicals, except that the formulas used aren’t approved. Banning one chemical found to be harmful only spurs the makers of the product to switch to another unknown product.

Furthermore, distributors often escape regulatory scrutiny by labeling the synthetic marijuana as “not for human consumption”. The CDC, DEA and other agencies are therefore often chasing a ghost that is hard to pin down.

However, the authorities are now determined to hunt down and stamp out these dangerous products whose overdoses have reached crisis level and are spreading to various parts of the country.

The big question on many people’s minds is that if this is happening in Washington, D.C., where marijuana is legal, can something be done to make the legal product more affordable for those with limited means? You can bet your last dollar that Marijuana Company of America Inc. (OTC: MCOA) and NUGL Inc. (OTC: NUGL) are praying that these products be wiped out so that the industry doesn’t get a bad reputation at this early stage.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Cannabis and Crypto

Cannabis firms have fought regulations and misconceptions for quite a long time as they have made attempts to inform the public on the medical benefits of the plant. In the recent couple of years, cannabis companies have started recording a surge in interest, as evidenced by their monthly record sales. Investors in Wall Street project that the industry will attain a valuation of $75 billion by the end of 2030.

Almost coincidentally, cryptos have also been enjoying a surge in popularity, with values of top cryptocurrencies such as bitcoin and Ethereum hitting record levels. Toward the end of 2017, the total market capitalization of the cryptocurrency industry hit $600 billion.

Apart from the growth prospects of the two industries, both experience legal uncertainty, high-risk environments and tighter government regulations. This makes cannabis and cryptos perfect partners.

How Blockchain is Facilitating Cannabis Trade

The blockchain technology that is the backbone of crypto transactions can help the cannabis industry to secure its exchange transactions. The cannabis trade has been criticized for channeling funds into the black market. With the blockchain, these worries can be put to rest and loopholes for fraud and funds leakages into the underworld sealed.

When this happens, both the crypto and cannabis industries can legitimize their activities in today’s dynamic modern economy. For instance, in the United States, only Alaska, Washington, Oregon, California, Nevada, Colorado, Vermont, Maine and Massachusetts have legalized marijuana for both recreation and medical use. The rest of the states have legalized the drug only for medical use.

Using cryptocurrency to facilitate transactions in the cannabis market is hugely important. This is because it widens the playing field and promotes inclusion to other groups all around the globe that previously were secluded from the trade. Since cannabis is still a Schedule I drug together with methamphetamine and heroin, players in this industry are barred from using bank accounts.

Any attempts by the banking system to facilitate cannabis payments could lead to dire legal consequences, including charges for money laundering. The exclusion of the banking system also renders the use of credit and debit cards impossible. Operations for cannabis businesses in the U.S. are cash-based.

Legitimizing the Cannabis Industry through Crypto

Cryptocurrency companies have come up to support trading activities and other development initiatives within the cannabis industry. One of the companies offering blockchain technology solutions customized for the cannabis industry is Pacific Software Inc. (OTC: PFSF). The company seeks to improve the compliance, transparency and efficiency of cannabis supply in states where it has been legalized.

Cannabis companies and traders who want to use the company’s Hyperledger blockchain applications are required to pay transaction fees, cash, loyalties and other forms of payment depending on the nature of the transactions.

GreenBox POS, LLC (OTC: GRBX) has also built customized payment solutions for different industries, including cannabis. The point of sale system is fully integrated, easy to use and intuitive.

By connecting buyers and sellers, crypto firms are creating a legitimate, centralized online meeting place where cannabis enthusiasts can share information and engage with one another. Usually, participants are rewarded with crypto coins that can be exchanged for goods and services or converted to fiat currency.

Any effort to boost accountability and transparency in the logistics and supply chain of cannabis is therefore welcome. The adoption of blockchain technology is yielding positive effects by fighting the social stigma around the sale and use of marijuana. As this positive ecosystem expands, buyers and sellers will feel safe, just like any other participants in a market platform.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Canadian Cannabis Legalization Set to Transform the Industrial Hemp Industry

CannabisNewsWire Editorial Coverage: The legalization of cannabis in Canada is about to bring big changes not just for medical cannabis companies but for hemp growers as well.

  • The law legalizing recreational cannabis in Canada will come into force on October 17.
  • This will create new opportunities for hemp growers to produce the plant for CBD extraction.
  • Hemp growers will now be able to profit from all parts of the plant.
  • Cannabis companies are experimenting with growing techniques, expanding their businesses, and seeking supply agreements in preparation for the change.

Marijuana Company of America Inc. (OTC: MCOA) (MCOA Profile), which grows industrial hemp in Canada, will now be able to sell leaves and flowers as well as other parts of its plants, and is preserving this year’s crop in preparation for the change. In the United States, Isodiol International, Inc. (OTC: ISOLF) is raising the profile of the industry through a celebrity partnership and the expansion of its retail chain. Aurora Cannabis, Inc. (OTC: ACBFF) has been acquiring financing to fund a program of expansions and takeovers, preparing the way to dominate the American market. Organigram Holdings, Inc. (OTC: OGRMF) and Emerald Health Therapeutics (OTC: EMHTF) have both set up a string of…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Massachusetts Credit Union to Offer Banking Services to Cannabis Industry

The GFA Federal Credit Union has become the first financial institution to announce that it is opening its doors to recreational and medical cannabis businesses in Massachusetts.

The announcement, due to take effect on October 1, brings a huge sigh of relief to numerous legitimate cannabis businesses that have struggled to attain the same level of recognition as other kinds of legal businesses within the state.

GFA Credit Union revealed that it studied the legal and business sense of making its move for about a year and finally decided to open its doors to this young industry.

GFA’s CEO, Tina Sbrega, said that its decision was primarily motivated by public safety concerns regarding such huge amounts of cash being left on the street. Robberies, money laundering, tax evasion and other related crimes were likely to escalate as the industry, currently worth millions of dollars in the state of Massachusetts, was left to operate as a cash-based industry.

Her public safety concerns are echoed by law enforcement agencies who welcomed the decision to provide banking services to the cannabis industry.

To be fair, Tina Sbrega admitted that GFA stands to benefit by adding businesses in the marijuana industry to its clientele.

However, not all is rosy for the cannabis industry as yet.

Initially, GFA Federal Credit Union will only accept a limited number of cannabis businesses as clients. Those selected businesses must meet all the existing requirements for operating a recreational or medical cannabis establishment. For example, the businesses must be licensed and have a letter of approval from the local authority where that business is based.

This restriction on how many cannabis businesses will be allowed to become GFA clients will leave all the others in the cold, unless more financial institutions step up to the plate and absorb them.

Many financial institutions are likely to drag their feet on this issue since they are unsure about the likely legal complications that may come from dealing with players in an industry that is regarded as illegal at the federal level. However, it is hoped that more will eventually follow GFA’s lead in order to get their cut of the pie presented by the recreational and medical cannabis industry.

The second speed bump for cannabis businesses is that even those lucky few who are taken on as GFA Credit Union clients will not immediately have access to loans to finance their operations. The credit union says that it will consider starting loan disbursements next year.

GFA Federal Credit Union wants to use these initial months of taking on cannabis businesses as clients to study how this relationship pans out before expanding to the provision of loans.

As any optimist would put it, the step by GFA Federal Credit Union may be small, but it is a major trail-blazing step that is sure to change the relationship between cannabis businesses and financial institutions for the better. At the very least, it is a major piece of good news for companies like Green Hygienics Holdings Inc. (GRYN) and GreenBox POS, LLC (GRBX) that may sniff new opportunities for growth and expansion from this horizon that has been expanded by the events in Massachusetts.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – UCLA Team to Investigate the Painkilling Effects of Cannabis

The U.S. Centers for Disease Control and Prevention (CDC) reported that 42,000 Americans died from an overdose of opioids in 2016 alone. Meanwhile, the consumption of cannabis by members of the American public has been growing rapidly over the years. How are these two issues related to the planned research on cannabis?

Plenty of anecdotal evidence exists to support the claim that cannabis has painkilling abilities. Several scientific studies also point to the possibility of cannabis having painkilling effects. However, little reliable scientific information is available to support or disprove those claims.

That may no longer be the case if the proposed study by a team of researchers from the University of California Los Angeles (UCLA) is completed successfully.

The researchers would like to ascertain what combination of CBD and THC provides the highest degree of painkilling effects for opioid patients.

Dr. Jeffrey Chen is the Executive Director of the Cannabis Research Initiative, which came up with the idea of conducting this study.

The actual study was designed by a professor of psychiatry and pharmacology, Edythe London. She explained that the research isn’t intended to provide evidence for or against the cannabis industry. The study is a scientific undertaking to understand a substance that is reputed to have so many medicinal effects.

The double-blind, placebo-controlled clinical study seeks to shed some light on one particular claim, the claim that cannabis can help to ease the pain suffered by patients.

The success of the study in proving that cannabis can combat pain would provide a glimmer of hope that a solution may be at hand for the opioid crisis facing the nation. Such a solution is desperately wanted, given the fact that about 40 percent of the opioid overdose fatalities reported by the CDC in 2016 were connected to prescription opioids.

Dr. Chen points out that the scientific community needs to play catch up quickly so that more information can be available to the public about cannabis. This information could save people from falling for yet-to-be-substantiated claims by cannabis product manufacturers.

However, the researchers have a huge task to overcome two major obstacles before the study can commence.

First, cannabis is federally regarded as a schedule 1 controlled substance, “a substance without any medical value and has a high potential for addictiveness.” The researchers must convince the Food and Drug Administration (FDA), as well as the Drug Enforcement Agency (DEA), to grant them permission to proceed with the study. It isn’t clear how easy, or how quickly, such regulatory approval can be secured.

Secondly, the researchers must look for funding for their study. Some money has been secured from UCLA’s Semel Institute for Neuroscience and Human Behavior and from some private donors. Additional funding requests have been made to local and federal sources. Entities like Canopy Rivers Corporation (TSX: WEED) (NYSE: CGC) and FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) must be keeping their fingers crossed, hoping that the necessary funding and approval is obtained so that the debate on the painkilling effects of marijuana can be put to rest once and for all.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Canadian Cannabis Investors at Risk of US Entry Bans

In a disturbing development, Canadians who have invested in the cannabis industry now face the risk of being banned permanently from entering the United States. This reality came to light when a prominent Canadian venture capitalist, Sam Znaimer, was told he was permanently barred from entering the U.S. due to his equity holdings in American cannabis companies whose shares are publicly traded on Canadian stock exchanges, such as the Toronto Stock Exchange.

He was shocked by the decision, since no single question had been posed regarding whether or not he consumed cannabis.

His shock is understandable given the fact that many people have shares in investment vehicles, such as mutual funds, and those investors have no clue where that money is channeled in order to earn the investor a return on his or her investment.

The example above is just one of a growing number of similar bans handed out by the Customs and Border Protection department of the U.S.

For now, it seems only those who have invested in American cannabis companies are being targeted. However, CBP (Customs and Border Protection) officials have revealed that even those who consume marijuana could be affected, especially when the smell is detected while pre-entry checks are being done at border crossings.

The view of the U.S authorities is that cannabis is a controlled substance, so anyone associated with it contravenes U.S. law and may be denied entry. However, no blanket action is foreseen, and border officials will exercise their discretion in enforcing the eligibility requirements for any alien trying to enter the U.S.

People who have been banned from entering the U.S. due to their connections to the cannabis industry will unfortunately have no recourse regarding the ban. However, the affected persons can apply for a temporary waiver so that they can be allowed into the U.S.

The process of obtaining the waiver is likely to be drawn out and very expensive, since there will be legal fees and application fees. There is no guarantee that whoever applies for the waiver will get it.

The risk of being barred from entering the U.S. is likely to put a damper on people who were considering investing in cannabis stocks. This fear is certainly real for Americans, since cannabis is illegal at the federal level. By law, Americans can’t be denied entry as they return from abroad, but that is little comfort since other actions could possibly be taken against them now or in the future.

It remains to be seen how cannabis players, such as Marijuana Company of America, Inc. (MCOA) and Medical Cannabis Payment Solutions (REFG), will be affected in the medium- and long-term by the tough stance taken by the U.S Customs and Border Protection agency.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

420 with CNW – Study Finds Marijuana Use Among Older Americans Has Doubled

A study published recently in the journal Drug and Alcohol Dependence has revealed that the use of cannabis among older Americans has increased remarkably from the level where it was a decade earlier.

The rise was 100 percent among baby boomers (those aged 50 to 64-years), since cannabis use prevalence rose from 4.5 percent a decade ago to 9 percent, according to data collected from 2015 to 2016.

Older adults (those aged 65 and above) increased their use of cannabis exponentially from 0.4 percent in 2005/2006 to nearly 3 percent 10 years later.

It is also noteworthy that more than half of surveyed baby boomers confessed during the study that they had used marijuana at least once by the age of 21. In contrast, less than a quarter of the older adults (65 and older) admitted to have used cannabis at age 21 or younger.

It is also important to note that a significant proportion of the seniors revealed that they used cannabis upon the recommendation of a doctor. The legalization of medical cannabis may therefore provide one of the possible reasons why older Americans are increasingly using pot.

Another possible reason why cannabis use could have increased among the age groups covered in the study is that society has evolved in the way it regards cannabis. There is a growing level of acceptance of marijuana, and this may explain why those who use it are willing to admit it during surveys.

However, a few professionals are expressing some concerns about the rising use of cannabis by older Americans. First, the strains of the plant currently available may be very potent when compared to what the baby boomers and those older consumed decades ago. Accidental overuse may therefore result from exposure to these stronger strains.

Secondly, many older citizens have chronic health challenges, such as high blood pressure and diabetes. There are fears that cannabis consumption may interact adversely with the medications that seniors are taking for those ailments.

The advanced age of these older citizens may also mean that their bodies are less capable of handling the effects of cannabis, since most body systems may no longer be functioning as robustly as they once did during the younger days of those consuming marijuana.

This study highlights the need for further research on how cannabis use is affecting older Americans. Not much (cannabis-wise) is known about these age groups, yet a lot of information is available on the use of cannabis among teenagers. It would be interesting to hear what the participants in the legal cannabis industry, such as Cannabis Strategic Ventures, Inc. (NUGS) and The Flowr Corporation have to say about the implications of this study.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net